Hongqiang Yu

机构：Jiangnan University · ORCID：0009-0007-9852-6068

发表论文 32 篇 · 总被引 640 次 · h-index 11

代表论文

• p53 haploinsufficiency and increased mTOR signalling define a subset of aggressive hepatocellular carcinoma (2020 · Journal of Hepatology · 被引 122)
• Promoting effect of baicalin on nitric oxide production in CMECs via activating the PI3K-AKT-eNOS pathway attenuates myocardial ischemia–reperfusion injury (2019 · Phytomedicine · 被引 93)
• Elevated FBXL6 expression in hepatocytes activates VRK2-transketolase-ROS-mTOR-mediated immune evasion and liver cancer metastasis in mice (2023 · Experimental & Molecular Medicine · 被引 32)
• Elevated FBXL6 activates both wild-type KRAS and mutant KRASG12D and drives HCC tumorigenesis via the ERK/mTOR/PRELID2/ROS axis in mice (2023 · Military Medical Research · 被引 31)
• Mutant Kras and mTOR crosstalk drives hepatocellular carcinoma development via PEG3/STAT3/BEX2 signaling (2022 · Theranostics · 被引 27)
• Elevated expression of WSB2 degrades p53 and activates the IGFBP3-AKT-mTOR-dependent pathway to drive hepatocellular carcinoma (2024 · Experimental & Molecular Medicine · 被引 26)